Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Balance and Mobility Performance Along the Alzheimer's Disease Spectrum.

Yoon B, Choi SH, Jeong JH, Park KW, Kim EJ, Hwang J, Jang JW, Kim HJ, Hong JY, Lee JM, Kang JH, Yoon SJ.

J Alzheimers Dis. 2019 Dec 2. doi: 10.3233/JAD-190601. [Epub ahead of print]

PMID:
31815691
2.

Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly.

Slot RE, Van Harten AC, Kester MI, Jongbloed W, Bouwman FH, Teunissen CE, Scheltens P, Veerhuis R, van der Flier WM.

J Alzheimers Dis. 2017;56(2):687-697. doi: 10.3233/JAD-151068.

PMID:
28035918
3.

Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).

Jessen F, Spottke A, Boecker H, Brosseron F, Buerger K, Catak C, Fliessbach K, Franke C, Fuentes M, Heneka MT, Janowitz D, Kilimann I, Laske C, Menne F, Nestor P, Peters O, Priller J, Pross V, Ramirez A, Schneider A, Speck O, Spruth EJ, Teipel S, Vukovich R, Westerteicher C, Wiltfang J, Wolfsgruber S, Wagner M, Düzel E.

Alzheimers Res Ther. 2018 Feb 7;10(1):15. doi: 10.1186/s13195-017-0314-2.

4.

Subjective memory complaint as a useful tool for the early detection of Alzheimer's disease.

Choe YM, Byun MS, Lee JH, Sohn BK, Lee DY, Kim JW.

Neuropsychiatr Dis Treat. 2018 Sep 24;14:2451-2460. doi: 10.2147/NDT.S174517. eCollection 2018.

5.

Clinical and Biomarker Characteristics According to Clinical Spectrum of Alzheimer's Disease (AD) in the Validation Cohort of Korean Brain Aging Study for the Early Diagnosis and Prediction of AD.

Hwang J, Jeong JH, Yoon SJ, Park KW, Kim EJ, Yoon B, Jang JW, Kim HJ, Hong JY, Lee JM, Park H, Kang JH, Choi YH, Park G, Hong J, Byun MS, Yi D, Kim YK, Lee DY, Choi SH.

J Clin Med. 2019 Mar 11;8(3). pii: E341. doi: 10.3390/jcm8030341.

6.

Screening for Cognitive Impairment in Older Adults: An Evidence Update for the U.S. Preventive Services Task Force [Internet].

Lin JS, O'Connor E, Rossom RC, Perdue LA, Burda BU, Thompson M, Eckstrom E.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Nov.

7.

Improvement of Screening Accuracy of Mini-Mental State Examination for Mild Cognitive Impairment and Non-Alzheimer's Disease Dementia by Supplementation of Verbal Fluency Performance.

Kim JW, Lee DY, Seo EH, Sohn BK, Choe YM, Kim SG, Park SY, Choo IH, Youn JC, Jhoo JH, Kim KW, Woo JI.

Psychiatry Investig. 2014 Jan;11(1):44-51. doi: 10.4306/pi.2014.11.1.44. Epub 2014 Jan 21.

8.

Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.

Mandecka M, Budziszewska M, Barczak A, Pepłońska B, Chodakowska-Żebrowska M, Filipek-Gliszczyńska A, Nesteruk M, Styczyńska M, Barcikowska M, Gabryelewicz T.

J Alzheimers Dis. 2016 Jul 29;54(1):157-68. doi: 10.3233/JAD-160176.

PMID:
27472875
9.

Correlation between functional mobility and cognitive performance in older adults with cognitive impairment.

Borges SM, Radanovic M, Forlenza OV.

Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2018 Jan;25(1):23-32. doi: 10.1080/13825585.2016.1258035. Epub 2016 Dec 9.

PMID:
27934540
10.

Subjective Spatial Navigation Complaints - A Frequent Symptom Reported by Patients with Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease.

Cerman J, Andel R, Laczo J, Vyhnalek M, Nedelska Z, Mokrisova I, Sheardova K, Hort J.

Curr Alzheimer Res. 2018;15(3):219-228. doi: 10.2174/1567205014666171120145349.

PMID:
29165083
11.

The implication of BDNF Val66Met polymorphism in progression from subjective cognitive decline to mild cognitive impairment and Alzheimer's disease: a 9-year follow-up study.

Bessi V, Mazzeo S, Bagnoli S, Padiglioni S, Carraro M, Piaceri I, Bracco L, Sorbi S, Nacmias B.

Eur Arch Psychiatry Clin Neurosci. 2019 Sep 27. doi: 10.1007/s00406-019-01069-y. [Epub ahead of print]

PMID:
31560105
12.

Activities of Daily Living and Depressive Symptoms in Patients with Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.

Stogmann E, Moser D, Klug S, Gleiss A, Auff E, Dal-Bianco P, Pusswald G, Lehrner J.

J Alzheimers Dis. 2016;49(4):1043-50. doi: 10.3233/JAD-150785.

PMID:
26577522
13.

From Subjective Cognitive Decline to Alzheimer's Disease: The Predictive Role of Neuropsychological Assessment, Personality Traits, and Cognitive Reserve. A 7-Year Follow-Up Study.

Bessi V, Mazzeo S, Padiglioni S, Piccini C, Nacmias B, Sorbi S, Bracco L.

J Alzheimers Dis. 2018;63(4):1523-1535. doi: 10.3233/JAD-171180.

PMID:
29782316
14.

Default Mode Network Connectivity Moderates the Relationship Between the APOE Genotype and Cognition and Individualizes Identification Across the Alzheimer's Disease Spectrum.

Zhu Y, Gong L, He C, Wang Q, Ren Q, Xie C; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2019;70(3):843-860. doi: 10.3233/JAD-190254.

PMID:
31282419
15.

Using Neuropsychological Process Scores to Identify Subtle Cognitive Decline and Predict Progression to Mild Cognitive Impairment.

Thomas KR, Edmonds EC, Eppig J, Salmon DP, Bondi MW; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2018;64(1):195-204. doi: 10.3233/JAD-180229.

PMID:
29865077
16.

Subjective Cognitive Decline and APOE ɛ4: A Systematic Review.

Ali JI, Smart CM, Gawryluk JR.

J Alzheimers Dis. 2018;65(1):303-320. doi: 10.3233/JAD-180248.

PMID:
30040718
17.

Usefulness of the Clock Drawing Test as a Cognitive Screening Instrument for Mild Cognitive Impairment and Mild Dementia: an Evaluation Using Three Scoring Systems.

Kim S, Jahng S, Yu KH, Lee BC, Kang Y.

Dement Neurocogn Disord. 2018 Sep;17(3):100-109. doi: 10.12779/dnd.2018.17.3.100. Epub 2018 Dec 9.

18.

Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.

De Beaumont L, Pelleieux S, Lamarre-Théroux L, Dea D, Poirier J; Alzheimer’s Disease Cooperative Study.

J Alzheimers Dis. 2016 Oct 4;54(3):913-922.

PMID:
27567841
19.

[Effect of apolipoprotein E genotype on magnetic resonance spectrum in amnestic mild cognitive impairment and Alzheimer's disease patients].

Zhu XQ, Zhou X, Zhao W, Zhang YM, Liu FJ, Cao J, Sun ZW.

Zhonghua Yi Xue Za Zhi. 2019 Apr 16;99(15):1156-1161. doi: 10.3760/cma.j.issn.0376-2491.2019.15.008. Chinese.

PMID:
31006219
20.

Functional Connectivity Changes Across the Spectrum of Subjective Cognitive Decline, Amnestic Mild Cognitive Impairment and Alzheimer's Disease.

Wang Z, Qiao K, Chen G, Sui D, Dong HM, Wang YS, Li HJ, Lu J, Zuo XN, Han Y.

Front Neuroinform. 2019 Apr 24;13:26. doi: 10.3389/fninf.2019.00026. eCollection 2019.

Supplemental Content

Support Center